This is in keeping with previous unbiased investigation of the changes to the transcriptome in response to eprenetapopt treatment in cancer cells, which detected no changes to p53 target genes but up-regulation of oxidative stress response genes, including SLC7A11 (13, 35). Here, TP53 is linked to cancer.